Nuveen Asset Management, LLC Foghorn Therapeutics Inc. Transaction History
Nuveen Asset Management, LLC
- $334 Billion
- Q2 2024
A detailed history of Nuveen Asset Management, LLC transactions in Foghorn Therapeutics Inc. stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 67,866 shares of FHTX stock, worth $635,225. This represents 0.0% of its overall portfolio holdings.
Number of Shares
67,866
Previous 53,963
25.76%
Holding current value
$635,225
Previous $362,000
7.73%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding FHTX
# of Institutions
72Shares Held
32.8MCall Options Held
6KPut Options Held
1.8K-
Flagship Pioneering Inc. Cambridge, MA12.7MShares$119 Million8.71% of portfolio
-
Bvf Inc San Francisco, CA5.3MShares$49.6 Million0.93% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY2.52MShares$23.6 Million0.3% of portfolio
-
Raymond James & Associates St Petersburg, FL2.34MShares$21.9 Million0.01% of portfolio
-
Euclidean Capital LLC New York, NY1.57MShares$14.7 Million1.14% of portfolio
About Foghorn Therapeutics Inc.
- Ticker FHTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,637,400
- Market Cap $390M
- Description
- Foghorn Therapeutics Inc., a clinical-stage biopharmaceutical company, discovers and develops medicines targeting genetically determined dependencies within the chromatin regulatory system. The company uses its proprietary Gene Traffic Control platform to identify, validate, and potentially drug targets within the system. It is developing FHD-28...